CTRI Number |
CTRI/2022/02/039889 [Registered on: 01/02/2022] Trial Registered Prospectively |
Last Modified On: |
19/07/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Siddha |
Study Design |
Single Arm Study |
Public Title of Study
|
Preclinical and clinical evaluation of the siddha classical drug ATHIMADHURA KULIGAI(oral administration) along with KADUGU ENNAI (external application) in the management of AUTISM SPECTRUM DISORDER. |
Scientific Title of Study
|
Preclinical and clinical evaluation of effect on oral administration of ATHIMADHURA KULIGAI along with external application KADUGU ENNAI in the management of MAANTHASANNI |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr B Tamil Elakkiya |
Designation |
II year PG Scholar |
Affiliation |
Government Siddha Medical College and Hospital |
Address |
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
TAMILNADU
INDIA
II year PG Scholar
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
TAMILNADU
INDIA
Tirunelveli TAMIL NADU 627002 India |
Phone |
9578169047 |
Fax |
|
Email |
balutamilelakkiya@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr K Shyamala MDs |
Designation |
Lecturer Grade II |
Affiliation |
Government Siddha Medical College and Hospital |
Address |
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
TAMILNADU
INDIA
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
TAMILNADU
INDIA
Tirunelveli TAMIL NADU 627002 India |
Phone |
9442277124 |
Fax |
|
Email |
shyamsujisathya@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr K Shyamala MDs |
Designation |
Lecturer Grade II |
Affiliation |
Government Siddha Medical College and Hospital |
Address |
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
TAMILNADU
INDIA
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
TAMILNADU
INDIA
Tirunelveli TAMIL NADU 627002 India |
Phone |
9442277124 |
Fax |
|
Email |
shyamsujisathya@gmail.com |
|
Source of Monetary or Material Support
|
Government Siddha Medical College and Hopsital |
|
Primary Sponsor
|
Name |
DrBTamil Elakkiya |
Address |
II year PG Scholar
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
627002.
|
Type of Sponsor |
Other [self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr B Tamil Elakkiya |
Government Siddha Medical College and Hospital |
Government Siddha Medical College and Hopsital
Palayamkottai
Tirunelveli
627002.
Tirunelveli TAMIL NADU |
9578169047
balutamilelakkiya@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethical Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: F840||Autistic disorder, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
ATHIMADHURA KULIGAI |
1 pill twice a day with honey for 45 days. |
Intervention |
KADUGU ENNAI |
Thuvalai 45days |
Comparator Agent |
Nil |
Nil |
|
Inclusion Criteria
|
Age From |
2.00 Year(s) |
Age To |
12.00 Year(s) |
Gender |
Both |
Details |
1.Children have lack of eye contact
2.lack of response
3.Repeatative or restricted behaviour
4.Unawareness of natural urges
5.Acquired speech or lost it
6.Unusual senstivity to sensory stimuli |
|
ExclusionCriteria |
Details |
1.Children above 12 years
2.Children below 2 years
3.Seevere and recurrent seizures
4.ADHD
5.CP
6.Infantile hemiplegia
7.Congenital anomalies |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Managing clinical symptoms |
45 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
Nil |
Nil |
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
03/02/2022 |
Date of Study Completion (India) |
17/07/2023 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
It is a single arm clinical trial for preclinical and clinical evaluation of the effect on oral administration of ATHIMADHURA KULIGAI along with external application of KADUGU ENNAI in the management of MAANTHASANNI |